drugset / Trial / NCT00612950
Beta-Cell Function After Near-Normalisation of Blood Glucose
RandomizedSingle-groupSingle-blindBasic science
Summary
The incretin effect is attenuated in patients with type 2 diabetes mellitus partly due to impaired potentiation of beta-cell responsiveness to glucose by glucose dependent insulinotropic polypeptide and glucagon-like peptide-1 respectively. The aim of the present study was to investigate whether 4 weeks of near-normalization of blood glucose could improve the insulin responses to GIP and GLP-1 in patients with type 2 diabetes.
Timeline
- Start
- 2006-10
- Primary completion
- 2007-02
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GLP-1 | Peptide | 0.5 unknown | — |
| Subject | Glucose-dependent Insulinotropic Polypeptide | Peptide | 1.5 unknown | — |